FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367298102> ?p ?o ?g. }

• W4367298102 abstract "Abstract Microglia, the innate immune cells of the brain, are activated by damage or disease. In mouse models of amyotrophic lateral sclerosis (ALS), microglia shift from neurotrophic to neurotoxic states with disease progression. It remains unclear how human microglia change relative to the TAR DNA-binding protein 43 (TDP-43) aggregation that occurs in 97% of ALS cases. Here we examine spatial relationships between microglial activation and TDP-43 pathology in brain tissue from people with ALS and from a TDP-43-driven ALS mouse model. Post-mortem human brain tissue from the Neurological Foundation Human Brain Bank was obtained from 10 control and 10 ALS cases in parallel with brain tissue from a bigenic NEFH -tTA/ tetO -hTDP-43∆NLS (rNLS) mouse model of ALS at disease onset, early disease, and late disease stages. The spatiotemporal relationship between microglial activation and ALS pathology was determined by investigating microglial functional marker expression in brain regions with low and high TDP-43 burden at end-stage human disease: hippocampus and motor cortex, respectively. Sections were immunohistochemically labelled with a two-round multiplexed antibody panel against; microglial functional markers (L-ferritin, HLA-DR, CD74, CD68, and Iba1), a neuronal marker, an astrocyte marker, and pathological phosphorylated TDP-43 (pTDP-43). Single-cell levels of microglial functional markers were quantified using custom analysis pipelines and mapped to anatomical regions and ALS pathology. We identified a significant increase in microglial Iba1 and CD68 expression in the human ALS motor cortex, with microglial CD68 being significantly correlated with pTDP-43 pathology load. We also identified two subpopulations of microglia enriched in the ALS motor cortex that were defined by high L-ferritin expression. A similar pattern of microglial changes was observed in the rNLS mouse, with an increase first in CD68 and then in L-ferritin expression, with both occurring only after pTDP-43 inclusions were detectable. Our data strongly suggest that microglia are phagocytic at early-stage ALS but transition to a dysfunctional state at end-stage disease, and that these functional states are driven by pTDP-43 aggregation. Overall, these findings enhance our understanding of microglial phenotypes and function in ALS." @default.
• W4367298102 created "2023-04-29" @default.
• W4367298102 creator A5027978540 @default.
• W4367298102 creator A5032047480 @default.
• W4367298102 creator A5032886408 @default.
• W4367298102 creator A5039639173 @default.
• W4367298102 creator A5049161020 @default.
• W4367298102 creator A5057038324 @default.
• W4367298102 creator A5078324228 @default.
• W4367298102 creator A5085666861 @default.
• W4367298102 creator A5089619118 @default.
• W4367298102 date "2023-04-28" @default.
• W4367298102 modified "2023-10-18" @default.
• W4367298102 title "Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain" @default.
• W4367298102 cites W1503916499 @default.
• W4367298102 cites W1539625195 @default.
• W4367298102 cites W1576915427 @default.
• W4367298102 cites W1667616536 @default.
• W4367298102 cites W1967086577 @default.
• W4367298102 cites W1971798829 @default.
• W4367298102 cites W1974485241 @default.
• W4367298102 cites W1974626393 @default.
• W4367298102 cites W1987138690 @default.
• W4367298102 cites W1996024251 @default.
• W4367298102 cites W2003618511 @default.
• W4367298102 cites W2010652292 @default.
• W4367298102 cites W2026141598 @default.
• W4367298102 cites W2028902268 @default.
• W4367298102 cites W2045262404 @default.
• W4367298102 cites W2046957687 @default.
• W4367298102 cites W2053176712 @default.
• W4367298102 cites W2053863700 @default.
• W4367298102 cites W2055289466 @default.
• W4367298102 cites W2060799374 @default.
• W4367298102 cites W2067267561 @default.
• W4367298102 cites W2070712250 @default.
• W4367298102 cites W2072210142 @default.
• W4367298102 cites W2076376940 @default.
• W4367298102 cites W2080097564 @default.
• W4367298102 cites W2082414904 @default.
• W4367298102 cites W2112516157 @default.
• W4367298102 cites W2114803648 @default.
• W4367298102 cites W2135768865 @default.
• W4367298102 cites W2137199534 @default.
• W4367298102 cites W2140380746 @default.
• W4367298102 cites W2144610554 @default.
• W4367298102 cites W2144621689 @default.
• W4367298102 cites W2159619745 @default.
• W4367298102 cites W2170706621 @default.
• W4367298102 cites W2291291090 @default.
• W4367298102 cites W2606009055 @default.
• W4367298102 cites W2620516100 @default.
• W4367298102 cites W2622807556 @default.
• W4367298102 cites W2720849841 @default.
• W4367298102 cites W2788797941 @default.
• W4367298102 cites W2801351945 @default.
• W4367298102 cites W2810948711 @default.
• W4367298102 cites W2822300386 @default.
• W4367298102 cites W2916020270 @default.
• W4367298102 cites W2955120761 @default.
• W4367298102 cites W2989747508 @default.
• W4367298102 cites W2990200213 @default.
• W4367298102 cites W2995882197 @default.
• W4367298102 cites W3022946221 @default.
• W4367298102 cites W3038275062 @default.
• W4367298102 cites W3042540255 @default.
• W4367298102 cites W3043193619 @default.
• W4367298102 cites W3043598318 @default.
• W4367298102 cites W3093508648 @default.
• W4367298102 cites W3159338697 @default.
• W4367298102 cites W3192481409 @default.
• W4367298102 cites W3194645698 @default.
• W4367298102 cites W4206934410 @default.
• W4367298102 cites W4210981518 @default.
• W4367298102 cites W4211216239 @default.
• W4367298102 cites W4214577587 @default.
• W4367298102 cites W4226174907 @default.
• W4367298102 cites W4294916248 @default.
• W4367298102 cites W4308150510 @default.
• W4367298102 cites W4310954846 @default.
• W4367298102 cites W4317604207 @default.
• W4367298102 cites W940680248 @default.
• W4367298102 cites W949737134 @default.
• W4367298102 doi "https://doi.org/10.1186/s40478-023-01561-6" @default.
• W4367298102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37118836" @default.
• W4367298102 hasPublicationYear "2023" @default.
• W4367298102 type Work @default.
• W4367298102 citedByCount "2" @default.
• W4367298102 countsByYear W43672981022023 @default.
• W4367298102 crossrefType "journal-article" @default.
• W4367298102 hasAuthorship W4367298102A5027978540 @default.
• W4367298102 hasAuthorship W4367298102A5032047480 @default.
• W4367298102 hasAuthorship W4367298102A5032886408 @default.
• W4367298102 hasAuthorship W4367298102A5039639173 @default.
• W4367298102 hasAuthorship W4367298102A5049161020 @default.
• W4367298102 hasAuthorship W4367298102A5057038324 @default.
• W4367298102 hasAuthorship W4367298102A5078324228 @default.
• W4367298102 hasAuthorship W4367298102A5085666861 @default.
• W4367298102 hasAuthorship W4367298102A5089619118 @default.
• W4367298102 hasBestOaLocation W43672981021 @default.

• next